A drug delivery system comprising a controller adapted to detect when a given user-actuated operation being part of the expelling of an amount of drug is performed, record detected operations as a function of time, and estimate, based on recorded operations, time parameters for the detected operations, thereby providing time parameters for a medical regimen on which the detected operations are assumed to be based upon.

A wound therapy system includes a negative pressure circuit, a pump, a pressure sensor, and a controller. The negative pressure circuit applies negative pressure to a wound. The pump is fluidly coupled to the negative pressure circuit and produces a negative pressure at the wound or within the negative pressure circuit. The pressure sensor measures the negative pressure within the negative pressure circuit or the wound. The controller performs a testing procedure including a first drawdown period, a leak rate determination period, a vent period, and a second drawdown period. The controller is configured to receive one or more pressure measurements of the pressure sensor over the leak rate determination period to determine a leak rate parameter, monitor an amount of elapsed time over the second drawdown period to determine a drawdown parameter, and estimate a volume of the wound based on the leak rate parameter and the drawdown parameter.

The invention relates to an injection device which includes a handle and a guard which together enclose a movable cartridge which can contain liquid material to be injected, and further enclose a movable injector that includes a needle, the needle being attached to a housing where the housing is attached to the cartridge, the device also including a delivery mechanism whereby the needle is moved from a retracted to an extended position, and independently the volume of the chamber may be adjusted to expel the contents thereof through the needle and into a subject in need thereof. The injection device may be communicatively connected to a control unit so as to provide a dermal injection system.

Apparatus and associated methods relate to a catheter manipulation handle with user interface controls for steering a catheter in situ while providing an augmented (e.g., motorized, powered and tunable precision steering, and perforation safeguards) control and feedback user experience. In an illustrative example, the catheter manipulation handle may provide motor assisted operation to automatically rotate and/or deflect a distal tip of the catheter to steer and guide the distal tip to a target location in the patient's vasculature system. The augmented feedback may include, for example, haptic feedback via the handle. Haptic, audible, and/or visual feedback via the handle may indicate, for example, proximity or engagement of the distal tip with sensitive tissue. In some examples, the handle's augmented operation may advantageously amplify feedback signals to enhance the user's perception of the patient's safety with respect to the safe passage of the distal tip through the patient's vasculature.

The present disclosure presents systems, devices and methods for administration of a therapeutic fluid to the body of a patient at a transient basal delivery profile, and enabling modification of the transient profile. Some embodiments include a user interface enabling input of one or more transient basal related parameters, and a processor having a basal programming application operating thereon. The basal programming application configured for determining a transient basal profile based on at least one or more transient basal related parameters. The transient basal profile comprises a plurality of phases and wherein each of the plurality of phases is characterized by a duration and at least one basal rate. In some embodiments, at least one of the plurality of phases includes either a basal overshot or a basal undershot. Some embodiments may also include a pump for dispensing the therapeutic fluid from a reservoir to the body of the patient.

Optical data is obtained from a pair of breasts, employing a simultaneous bilateral referencing protocol, and is subsequently analyzed employing a self-referencing data analysis method. Optical measurements can be performed on both breasts simultaneously under various protocols, including resting-state measures and evoked responses. Sensing hardware and data collection protocols are economical and can be implemented without patient discomfort. The natural variance inherently associated with optical measures of the breast is reduced by: imposition of substantially symmetric boundary conditions; collection of simultaneous bilateral dynamic measures; referencing measurement data of one breast to measurement data from another.

A gas delivery system supplying a body cavity with a given gas includes a first guide pipe for supplying the given gas into the body cavity and a second guide pipe installed in the first guide pipe for supplying the given gas into the body cavity at a flow velocity that differs from that of the first guide pipe. A flow velocity of the given gas that is supplied from a first conduit which is formed by the first guide pipe and the second guide pipe is faster than a flow velocity of the given gas that is supplied from a second conduit which is formed in the second guide pipe.

A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.

The present disclosure pertains to a parameter translation system configured to determine respiratory therapy control parameters. When a subject is prescribed respiratory therapy, his or her regimen will likely include receiving therapy from several different respiratory therapy devices. Respiratory therapy devices are often designed and/or approved for a niche depending on acuity of respiratory distress and/or insufficiency in the subject, the physical location of the subject, and/or other factors. These respiratory devices are made by a variety of manufacturers and deliver therapy with a variety of therapy regimes, settings, alarm parameters, and/or other control parameters. It is a laborious process to transfer such control parameters between two or more respiratory therapy devices. The present system facilitates translating these control parameters from one respiratory therapy device to another respiratory therapy device so the subject continues receiving the prescribed respiratory therapy when he or she switches from one device to another.

A portable, efficient, integrated humidification system for use, e.g., with a positive airway pressure devices. The portable, efficient, integrated humidification system described herein offers many advantages over current humidification systems! There are many advantages to a portable respiratory humidifier. Portability reduces the amount of space the humidifier occupies in the user's bedroom environment. Portability enhances travel for the user. With less to pack, carry, and manage, the user is more likely to remain adherent to therapy when not at home. Portability allows for better utilization in recreational vehicles, while camping, in foreign countries, in the sleeping cabins of trucks or airliners, and on marine craft.